Exploring the role of indigenously developed novel humanized cd19-directed chimeric antigen receptor(hcar19) t-cells for relapsed/refractory b-cell acute lymphoblastic leukemia- a pilot open-label single-arm phase-i study

PEDIATRIC BLOOD & CANCER(2022)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要